CASRAI Dictionary

Tag: NIH no-cost extension

  • UKRI COVID Grant Extensions: The CoA Audit Trail

    UKRI COVID grant extensions — formally the UKRI COVID-19 Grant Extension Allocation (CoA) — were a costed, time-boxed funding mechanism used between 2020 and 2021 to extend research and fellowship awards disrupted by the pandemic. Although the scheme closed to new applications years ago, its expenditure still falls inside institutional audit cycles, because UKRI’s funding assurance reviews and grant-condition checks operate on multi-year lookback windows, not calendar-year cut-offs.

    The CoA is defined by UKRI as a supplementary, costed award — distinct from an ordinary no-cost extension — issued to sustain UKRI grant-funded research and fellowships affected by the pandemic, subject to its own terms, conditions and reporting deadlines.

    What was the UKRI COVID-19 Grant Extension Allocation (CoA)?

    The CoA ran from 2020 into 2021 as UKRI’s principal response to pandemic-related disruption of active grants. UKRI’s own FAQ describes its aim as providing “UK organisations with resources to sustain UKRI grant-funded research and fellowships affected by” the pandemic. Unlike a routine no-cost extension, which extends time only, the CoA was a genuine additional award: UKRI’s terms and conditions state plainly that “extensions of CoA can only be offered in specific circumstances and will be supported through an additional award.”

    A related, narrower scheme targeted doctoral students specifically. In February 2021, a written ministerial statement to Parliament confirmed £44 million of urgent funding for up to six-month extensions for PhD students in their final year unable to complete their studies. UKRI later reported a further £19 million committed under the Doctoral Extensions Policy Phase 2 Awards, published in a full report dated February 2025, covering students who could not mitigate pandemic delays through the initial phase of support.

    Both strands closed to new applications once their windows lapsed, but institutions that drew on either allocation retained reporting obligations — a Final Report and a Final Expenditure Statement — that created the audit trail now being revisited.

    Why UKRI COVID grant extensions still surface in institutional audits

    Institutional audits and UKRI funding-assurance reviews do not treat 2020-21 expenditure as closed simply because the pandemic has receded. Grant conditions require institutions to retain records for a defined period after a grant’s Final Expenditure Statement, and CoA-funded costs sit inside exactly the same retention and eligibility rules as any other award expenditure.

    Three forces keep the CoA in scope for auditors in 2026:

    • Retention windows outlast the news cycle. Record-retention obligations attached to a grant run from the Final Expenditure Statement date, not from the original award date — so CoA awards accepted late in the scheme can still be inside their retention period.
    • Funding assurance reviews are cyclical, not one-off. UKRI’s assurance activity revisits institutional financial control on a rolling basis, which means expenditure from 2020-21 can legitimately fall inside a review conducted years later.
    • The CoA was a bespoke instrument, so its rules are easy to misapply. Because the CoA was a costed additional award rather than a standard no-cost extension, staff costs, equipment, and consumables charged against it must be tested against the CoA-specific terms and conditions — not the general no-cost-extension rules that apply to most current requests. Institutional audit teams that apply the wrong rule set are the most common source of a finding.

    CoA vs a standard no-cost extension: what changed under UKRI grant conditions

    The distinction between the CoA and today’s ordinary no-cost extension is the single most consequential fact for an audit reviewing pandemic-era files, and it is easy to lose years after the event.

    Feature UKRI COVID-19 Grant Extension Allocation (CoA) Standard no-cost extension (current UKRI grant conditions)
    Funding basis Costed — supported through an additional award No additional cost; time only
    Maximum duration Case-by-case, tied to pandemic disruption Up to 6 months over the grant’s lifetime for non-people-related reasons; up to the actual delay for people-related reasons (per UKRI guidance updated 7 May 2026)
    Application status Closed since 2021 Open, ongoing route via the grant’s award system
    Reporting obligation Final Report plus Final Expenditure Statement, due by end of 2021 Standard Final Expenditure Statement at the (extended) grant end date

    UKRI’s current guidance on requesting a change to a project confirms the modern no-cost-extension rule directly: “no-cost extensions due to non-people related reasons may not exceed six months over the lifetime of the grant, unless exceptions apply.” Extensions justified by people-related reasons — parental leave, sick leave, recruitment delay — may instead run for the actual length of the delay. Neither rule was designed with the CoA’s bespoke, costed structure in mind, which is exactly why an auditor applying today’s no-cost-extension test to a 2020-21 CoA award will misclassify the expenditure.

    What documentation satisfies auditors reviewing CoA-funded extensions

    Research offices preparing for a funding-assurance visit or an institutional audit that touches pandemic-era grants should be able to produce, for each CoA award:

    1. The original CoA award letter or additional-award confirmation, showing it was issued as a costed extension rather than a no-cost one.
    2. The stated justification for the extension, tied to a specific pandemic-related circumstance rather than a general reference to COVID-19.
    3. Timesheets or equivalent evidence for any staff costs charged against the additional award.
    4. The Final Report and Final Expenditure Statement submitted at scheme close, plus any correspondence extending those deadlines.
    5. A clear cross-reference showing which grant conditions — CoA-specific or standard — governed each cost line, so a reviewer does not default to the wrong rule set.

    Where a doctoral extension was funded under the separate £44 million or £19 million allocations described above, the same principle applies: keep the scheme-specific approval letter alongside the standard studentship file, because the eligibility criteria for those cohorts differ from both the CoA and the ordinary no-cost extension.

    Frequently asked questions

    What is the UKRI COVID-19 Grant Extension Allocation (CoA)?

    The CoA was a costed, additional UKRI award — not a standard no-cost extension — issued between 2020 and 2021 to sustain grant-funded research and fellowships disrupted by the pandemic. It closed to new applications once its funding window ended, but its terms still govern how that historic expenditure must be assessed in an audit.

    How long can a UKRI no-cost extension run under current grant conditions?

    Under UKRI guidance current as of May 2026, a no-cost extension for non-people-related reasons may not exceed six months over the lifetime of the grant, unless exceptions apply. Extensions justified by people-related reasons, such as parental or sick leave, may instead run for the length of the actual delay.

    Why do auditors still ask about COVID-era grant extensions?

    Grant record-retention obligations run from the Final Expenditure Statement date, and UKRI’s funding-assurance reviews revisit institutional financial control on a rolling cycle. Both mean CoA-funded expenditure from 2020-21 can still fall legitimately inside a current review, especially where cost lines were charged under bespoke, non-standard terms.

    Can an institution still apply for a new CoA extension today?

    No. The CoA closed to new applications once its funding window lapsed in 2021. Institutions cannot open new CoA claims; the only live task is ensuring historic CoA expenditure and its supporting evidence remain correctly documented against the scheme’s original, costed terms.

    For research offices, the practical implication is straightforward: pandemic-era grant files are not a closed chapter simply because the news cycle has moved on. Institutions that keep the CoA’s costed, bespoke terms clearly separated from today’s standard no-cost-extension rules — and can point an auditor to the correct rule set for each historic cost line — are the ones that clear a funding-assurance review without a finding. That discipline, more than any single retained document, is what the legacy of the CoA now demands of institutional grant administration.

    Research offices building broader institutional compliance capability may also find it useful to review general research administration practice alongside funder-specific rules such as these.

  • No-Cost Extension Grant: Funder Rules Guide

    A no-cost extension grant modification lets a research team keep working past the original award end date without any additional funding from the sponsor — it changes the calendar, not the budget. A no-cost extension (NCE) is a formal amendment to a grant’s period of performance that leaves the total award amount unchanged. This guide sets out what counts as valid justification, how the major funder routes differ, and what a research office needs to document before submitting a request.

    What is a no-cost extension grant?

    A no-cost extension is an extension of a grant’s project period, budget period, or both, granted without any increase to the sponsor’s financial contribution. It exists because research timelines rarely match the calendar exactly: equipment fails, staff leave, ethics approvals slip, or a dataset takes longer to collect than planned. Rather than losing the remaining scope of work, the awardee institution requests more time to finish it.

    Crucially, an NCE is not a mechanism for spending down leftover funds more slowly. Sponsors, including UKRI and the US federal agencies operating under the Uniform Guidance (2 CFR 200.309), require a programmatic reason — a scientific or operational cause for the delay — not simply the presence of unspent money. Unspent funds alone are a common but invalid justification, and reviewers are trained to reject requests that rely on it.

    Most systems distinguish two extension types: a grantee-authorised extension, which the institution can approve internally and simply notify the sponsor of, and a sponsor-approved extension, which requires the funder’s programme officer to review and sign off before the new end date takes effect. Which route applies depends entirely on the funder and on whether the award has already used its one-time automatic allowance.

    How do funder approval routes differ?

    No two funders handle no-cost extensions identically. Duration caps, the number of extensions permitted, and who holds approval authority all vary by sponsor, and a research office managing a mixed portfolio needs to track each one separately rather than applying a single house rule.

    Funder Typical maximum duration Approval authority Source
    UKRI Up to 6 months over the grant’s lifetime for non-people-related reasons (longer for parental leave, via a separate Je-S Grant Maintenance request) UKRI review; exceptions require case-by-case approval UKRI, “Requesting a change to your project” (updated 7 May 2026)
    Wellcome Up to 12 months Wellcome, subject to sufficient unspent funds Wellcome, “Grant end dates” funding guidance
    NIH Up to 12 months (first request) Grantee-institution self-authorised for the first extension; NIH approval required thereafter NIH Grants Policy Statement; Uniform Guidance 2 CFR 200.309
    NSF Up to 12 months (first request) Grantee-institution notifies via Research.gov; NSF approval required for a second request Uniform Guidance 2 CFR 200.309
    Cancer Research UK Set by case; resets the grant end date only Cancer Research UK review before the original end date Cancer Research UK, “Grant extensions and suspensions”
    Irish Research Council Set by case IRC review via a standard NCE request form, submitted in advance with justification Irish Research Council, NCE request form
    Horizon Europe Handled as a formal grant agreement amendment Submitted through the EU Funding & Tenders Portal before the original end date Horizon Europe Model Grant Agreement

    The pattern that matters for a research office is the split between delegated authority and sponsor-approved extensions. NIH and NSF delegate the first 12-month extension to the institution itself, which is why compliance still matters even when no sponsor sign-off is required — an internally approved extension that lacks proper justification on file can still be flagged at audit. UKRI, by contrast, caps non-people-related extensions at six months over the grant’s entire lifetime, which makes early planning essential on multi-year awards nearing that ceiling.

    How should research offices document and justify the request?

    A no-cost extension request stands or falls on its documentation. Reviewers — whether an internal sponsored-programmes office or an external programme officer — need a clear, scientifically grounded account of why the work is behind schedule and a credible plan to finish it within the new timeframe.

    A complete no-cost extension request package typically includes:

    • A dated request letter or form, on institutional letterhead, stating the current end date and the proposed new end date
    • A narrative justification tied to the original aims — for example, delayed recruitment, equipment failure, supply-chain delay, or loss of key personnel
    • A progress report summarising work completed and work remaining
    • A grant budget justification showing remaining unspent funds and how they will be used during the extension period
    • Confirmation that ethics, IRB, IACUC or equivalent approvals remain valid for the extended period
    • Departmental or sponsored-programmes-office sign-off before submission to the sponsor

    The request letter and the budget justification should read as two halves of one argument: the letter explains why more time is needed; the budget justification proves the remaining funds are sufficient and appropriately allocated to finish the work. Reviewers who receive a duration request without a matching budget rationale routinely send it back for revision, which costs the research office weeks it may not have close to the original end date.

    Timing discipline matters as much as content. Most funders set a submission window — commonly 10 to 90 days before the current end date — and a late request can be rejected outright regardless of justification quality. Building the no-cost extension conversation into the grant closeout report cycle, six months ahead of the projected end date, gives the office enough runway to gather sign-offs, confirm compliance approvals, and route the request through internal review before the deadline closes.

    Frequently asked questions

    What is a no-cost extension on a grant?

    A no-cost extension is a formal amendment that extends a grant’s project period, budget period, or both, without any additional funds from the sponsor. It allows a principal investigator to finish the original scope of work when the current end date is approaching but the research is not yet complete.

    How long can a no-cost extension be?

    The permitted length varies by funder. NIH and NSF typically allow a grantee-authorised first extension of up to 12 months; Wellcome considers requests up to 12 months; UKRI caps non-people-related extensions at six months over the grant’s entire lifetime.

    What is a blanket no-cost extension?

    A blanket no-cost extension is a single authorisation that applies an identical extension period across multiple awards at once, typically issued by a funder or institution in response to a system-wide disruption. It replaces the need for a separate justification letter on each individual grant affected by the same event.

    How does a no-cost extension work?

    The principal investigator identifies that work will not finish by the current end date, and the research office prepares a justification, progress report and budget statement. Depending on the funder, the institution either self-authorises the extension internally or submits the package for sponsor approval before the award is formally amended.

    What this means for research administration offices

    No-cost extensions sit at the intersection of compliance, forecasting and research administration. An office that treats them as routine paperwork risks two failure modes: internally approved extensions with weak documentation that surface at audit, and sponsor-approved requests submitted too close to the deadline to be processed in time. Neither outcome serves the institution or the funded research.

    The more resilient approach treats the no-cost extension policy of each major sponsor as a standing reference — alongside its grant closeout report requirements and the shared terminology in the CASRAI Dictionary — rather than something looked up fresh for every request. As portfolios diversify across UKRI, US federal agencies, charitable funders and Horizon Europe, the variance in caps and approval authority documented above is exactly the kind of detail that belongs in a research office’s internal policy library, reviewed whenever a funder updates its terms and conditions.

    For institutions building or refining that internal reference, mapping each active funder’s no-cost extension terms against submission deadlines — not against the calendar year — keeps the office ahead of the six-to-twelve-month windows most sponsors actually use.